Chin-Ting Huang
National Health Research Institutes(TW)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Microtubule and mitosis dynamics, Cytokine Signaling Pathways and Interactions, Acute Myeloid Leukemia Research, Cancer-related Molecular Pathways
Most-Cited Works
- → Fast-Forwarding Hit to Lead: Aurora and Epidermal Growth Factor Receptor Kinase Inhibitor Lead Identification(2010)68 cited
- → Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells(2011)54 cited
- → Optimization of Ligand and Lipophilic Efficiency To Identify an in Vivo Active Furano-Pyrimidine Aurora Kinase Inhibitor(2013)41 cited
- → EGFR and myosin II inhibitors cooperate to suppress EGFR‐T790M‐mutant NSCLC cells(2012)22 cited
- → Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer(2014)21 cited
- → Quercetin Cumulatively Enhances Copper Induction of Metallothionein in Intestinal Cells(2001)19 cited
- → Development of a Humanized Antibody Targeting Extracellular HSP90α to Suppress Endothelial-Mesenchymal Transition-Enhanced Tumor Growth of Pancreatic Adenocarcinoma Cells(2024)3 cited
- JMC - Fast-forwarding Hit to Lead - Supporting information - 2010(2013)
- → Abstract B211: Augmentation of Fas (CD95) signaling pathway sensitizes non-small cell lung cancer (NSCLC) cells.(2011)